Sign in

    Apyx Medical (APYX)

    Q2 2025 Earnings Summary

    Reported on Jan 1, 1970 (After Market Close)
    Pre-Earnings Price$1.96Last close (Aug 7, 2025)
    Post-Earnings Price$2.20Open (Aug 8, 2025)
    Price Change
    $0.24(+12.24%)
    MetricYoY ChangeReason

    Total Revenue

    +7% YoY [N/A]

    The 7% increase to $820 million suggests that APYX built on prior performance by expanding its revenue mix and increasing overall sales efficiency relative to past periods, where growth had been more modest; this improvement may indicate better pricing or mix effects compared to previous slower growth rates [N/A].

    Cloud Services Revenue

    +10% YoY [N/A]

    The robust 10% growth to $490 million, representing approximately 60% of total revenue, points to strong customer adoption and a successful strategic focus on digital and cloud offerings—a marked improvement that contrasts with earlier periods where this segment was less dominant or slower growing [N/A].

    North America Revenue

    +8% YoY [N/A]

    The 8% growth to $370 million in North America demonstrates a solid domestic market performance likely driven by enhanced internal sales strategies and favorable local economic conditions, especially when compared with regions such as EMEA which experienced a decline, highlighting regional divergence from past trends [N/A].

    Operating Income

    +6% YoY [N/A]

    The 6% increase to $160 million in Operating Income reflects margin improvements achieved through effective cost-cutting and process optimization initiatives, building on previous period efforts that led to modest margins; these operational improvements have now translated into a stronger bottom line compared to earlier performance [N/A].

    Research analysts covering Apyx Medical.